196 related articles for article (PubMed ID: 24696905)
1. Chronic viral hepatitis. Treatment progress, hopes for cures.
Mayo Clin Health Lett; 2014 Mar; 32(3):4-5. PubMed ID: 24696905
[No Abstract] [Full Text] [Related]
2. The comparative clinical effectiveness and value of simeprevir and sofosbuvir for chronic hepatitis C virus infection.
Ollendorf DA; Tice JA; Pearson SD
JAMA Intern Med; 2014 Jul; 174(7):1170-1. PubMed ID: 24798321
[No Abstract] [Full Text] [Related]
3. [Chronic hepatitis C. Interferon free therapy also in patients with liver cirrhosis].
MMW Fortschr Med; 2014 Dec; 156(21-22):97. PubMed ID: 25608420
[No Abstract] [Full Text] [Related]
4. [A new era in therapy of chronic hepatitis C].
Füessl HS
MMW Fortschr Med; 2015 Feb; 157(2):38. PubMed ID: 25743515
[No Abstract] [Full Text] [Related]
5. [New combination therapy increases chances of recovery].
Jäger-Becker D
MMW Fortschr Med; 2015 Feb; 157(3):70. PubMed ID: 25743682
[No Abstract] [Full Text] [Related]
6. [Therapy spectrum in hepatitis C extended. Newer NS3/4A protease inhibitor in chronic hepatitis C-GT1/4 infection].
MMW Fortschr Med; 2014 Jun; 156 Suppl 1():53. PubMed ID: 25026860
[No Abstract] [Full Text] [Related]
7. The high price of the new hepatitis C virus drugs.
Steinbrook R; Redberg RF
JAMA Intern Med; 2014 Jul; 174(7):1172. PubMed ID: 24798183
[No Abstract] [Full Text] [Related]
8. Special report: cost-effectiveness studies of new hepatitis C treatments.
Mark DH;
Technol Eval Cent Assess Program Exec Summ; 2015 Jan; 29(10):1-3. PubMed ID: 25962188
[No Abstract] [Full Text] [Related]
9. New drugs: simeprevir, sofosbuvir, and dolutegravir sodium.
Hussar DA; Jin ZJ
J Am Pharm Assoc (2003); 2014; 54(2):202-7. PubMed ID: 24632934
[No Abstract] [Full Text] [Related]
10. Treatment of chronic hepatitis C virus infection in the near future.
Cheinquer H
Ann Hepatol; 2013; 12(6):854-9. PubMed ID: 24114813
[No Abstract] [Full Text] [Related]
11. Hepatitis C.
Chan J
Dis Mon; 2014 May; 60(5):201-12. PubMed ID: 24863270
[No Abstract] [Full Text] [Related]
12. Advances in therapy for HIV/hepatitis C virus-coinfected patients in the liver transplant setting.
Campos-Varela I; Peters MG; Terrault NA
Clin Infect Dis; 2015 Jan; 60(1):108-16. PubMed ID: 25228702
[TBL] [Abstract][Full Text] [Related]
13. What are the management issues for hepatitis C in dialysis patients?: natural history of hepatitis C in dialysis populations.
Carrion AF; Martin P
Semin Dial; 2014; 27(5):446-8. PubMed ID: 25204876
[No Abstract] [Full Text] [Related]
14. The price of good health.
Nat Med; 2014 Apr; 20(4):319. PubMed ID: 24710362
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of drug-drug interactions upon addition of simeprevir- or sofosbuvir-containing treatment to medication profiles of patients with HIV and hepatitis C coinfection.
Patel N; Nasiri M; Koroglu A; Amin R; McGuey L; McNutt LA; Roman M; Miller C
AIDS Res Hum Retroviruses; 2015 Feb; 31(2):189-97. PubMed ID: 25432275
[TBL] [Abstract][Full Text] [Related]
16. Simeprevir (Olysio) for chronic hepatitis C.
Med Lett Drugs Ther; 2014 Jan; 56(1433):1-3. PubMed ID: 24419295
[No Abstract] [Full Text] [Related]
17. Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era.
Berden FA; Kievit W; Baak LC; Bakker CM; Beuers U; Boucher CA; Brouwer JT; Burger DM; van Erpecum KJ; van Hoek B; Hoepelman AI; Honkoop P; Kerbert-Dreteler MJ; de Knegt RJ; Koek GH; van Nieuwkerk CM; van Soest H; Tan AC; Vrolijk JM; Drenth JP
Neth J Med; 2014 Oct; 72(8):388-400. PubMed ID: 25387551
[TBL] [Abstract][Full Text] [Related]
18. WHO issues guidelines on HCV amid drug cost controversy.
Slomski A
JAMA; 2014 Jun; 311(22):2262-3. PubMed ID: 24915242
[No Abstract] [Full Text] [Related]
19. Hepatitis C virus: here comes all-oral treatment.
Dugum M; O'Shea R
Cleve Clin J Med; 2014 Mar; 81(3):159-72. PubMed ID: 24591471
[TBL] [Abstract][Full Text] [Related]
20. [New hepatitis C treatments: pharmacological considerations and potential for drug interactions].
Chtioui H; Buclin T; Moradpour D
Rev Med Suisse; 2014 Sep; 10(440):1600-4, 1606. PubMed ID: 25276998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
